Free access
Issue
Vet. Res.
Volume 32, Number 1, January-February 2001
Page(s) 1 - 30
DOI http://dx.doi.org/10.1051/vetres:2001106
How to cite this article Vet. Res. (2001) 1-30
  1. Abrams C.C., King A.M.Q., Belsham G.J., Assembly of foot-and-mouth disease virus empty capsids synthesized by a vaccinia virus expression system, J. Gen. Virol. 76 (1995) 3089-3098 [PubMed].
  2. Acharya R., Fry E., Stuart D., Fox G., Rowlands D., Brown, F., The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution, Nature 337 (1989) 709-716 [CrossRef] [PubMed].
  3. Agol V.I., Paul A.V., Wimmer E., Paradoxes of the replication of picornaviral genomes, Virus Res. 62 (1999) 129-147 [CrossRef] [PubMed].
  4. Alonso A., Gomes M.P.D., Martins M.A., Sondahl M.S., Detection of foot-and-mouth disease virus infection-associated antigen antibodies: comparison of the enzyme-linked immunoabsorbent assay and agar gel immunodiffusion test, Prev. Vet. Med. 9 (1990) 233-240 [CrossRef].
  5. Amadori M., Archetti I.L., Verardi R., Berneri C., Isolation of mononuclear cytotoxic cells from cattle vaccinated against foot-and-mouth disease virus, Arch. Virol. 122 (1992) 293-306 [CrossRef] [PubMed].
  6. Amaral-Doel C.M., Owen N.E., Ferris N.P., Kitching R.P., Doel T.R., Detection of foot-and-mouth disease viral sequences in clinical specimens and ethyleneimine-inactivated preparations by the polymerase chain reaction, Vaccine 11 (1993) 415-421 [CrossRef] [PubMed].
  7. Andino R., Rieckhof G.E., Achacoso P.L., Baltimore D., Poliovirus RNA synthesis utilizes an RNP complex formed around the 5'-end of viral RNA, EMBO J. 12 (1993) 3587-3598 [PubMed].
  8. Arlinghaus R.B., Polatnick J., The isolation of two enzyme-ribonucleic acid complexes involved in the synthesis of foot-and-mouth disease virus ribonucleic acid, Proc. Natl. Acad. Sci. USA 26 (1969) 821-829 [CrossRef].
  9. Armstrong R.M., Samuel A.R., Carpenter W.C., Kant R., Knowles N.J., A comparative study of serological and biochemical methods for strain differentiation of foot-and-mouth disease type A virus, Vet. Microbiol. 39 (1994) 285-298 [CrossRef] [PubMed].
  10. Arrowsmith A.E.M., A survey of foot-and-mouth disease type O strains from the Far East, Dev. Biol. Stand. 35 (1977) 221-230.
  11. Bachrach H.L., Foot-and-mouth disease virus, properties, molecular biology and immunogenicity, in: Romberger J.A. (Ed.), Beltsville Symposia in Agricultural Research. I. Virology in Agriculture, Allanheld, Osmun, Montclair, N.J., 1977, pp. 3-32.
  12. Bachrach H.L., Moore D.M., McKerche P.D., Polatnick J., Immune and antibody responses to an isolated capsid protein of food-and-mouth disease virus, J. Immunol. 115 (1975) 1636-1641 [PubMed].
  13. Bahnemann H.G., Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethyleneimine, Vaccine 8 (1990) 299-303 [CrossRef] [PubMed].
  14. Baranowski E., Sevilla N., Verdaguer N., Ruiz-Jarabo C.M., Beck E., Domingo E., Multiple virulence determinants of foot-and-mouth disease virus in cell culture, J. Virol. 72 (1998) 6362-6372 [PubMed].
  15. Baranowski E., Ruiz-Jarabo C.M., Sevilla N., Andreu D., Beck E., Domingo E., Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage, J. Virol. 74 (2000) 1641-1647 [CrossRef] [PubMed].
  16. Barnett P.V., Cox S.J., The role of small ruminants in the epidemiology and transmission of foot-and-mouth disease, Vet. J. 158 (1999) 6-13 [CrossRef] [PubMed].
  17. Barnett P.V., Ouldridge E.J., Rowlands D.J., Brown F., Parry N.R., Neutralizing epitopes of type O foot-and-mouth disease virus. I. Identification and characterization of three functionally independent, conformational sites, J. Gen. Virol. 70 (1989) 1483-1491 [PubMed].
  18. Barteling S.J., Vreeswijk J., Developement in foot-and-mouth disease vaccines, Vaccine 9 (1992) 75-88 [CrossRef].
  19. Baxt B., Becker, Y., The effect of peptides containing the arginine-glycine-aspartic acid sequence on the adsorption of foot-and-mouth disease virus to tissue culture cells, Virus Genes 4 (1990) 73-83 [CrossRef] [PubMed].
  20. Baxt B., Mason P.W., Foot-and-mouth disease virus undergoes restricted replication in macrophage cell cultures following FC receptor-mediated adsorption, Virology 207 (1995) 503-509 [CrossRef] [PubMed].
  21. Beard C.W., Mason P.W., Genetic determinants of altered virulence of Taiwanese foot-and-mouth disease virus, J. Virol. 71 (2000) 987-991 [CrossRef].
  22. Beck E., Strohmaier K. Subtyping of european foot-and-mouth disease virus strains by nucleotide sequence determination, J. Virol. 61 (1987) 1621-1629 [PubMed].
  23. Beck E., Forss S., Strebel K., Cattaneo R., Feil G., Structure of the FMDV translation initiation site and of the structural proteins, Nucleic Acids Res. 11 (1983) 7873-7885 [CrossRef] [PubMed].
  24. Becker Y., The need for cellular and humoral immune responses in bovines to ensure protection from foot-and-mouth disease virus (FMDV)-a point of view, Virus Genes 8 (1993) 199-214 [CrossRef].
  25. Belsham G.J., Distinctive features of foot-and-mouth disease virus, a member of the picornavirus family; aspects of virus protein synthesis, protein processing and structure, Prog. Biophys. Mol. Biol. 60 (1993) 241-260 [PubMed].
  26. Belsham G.J., Brangwyn J.K., A region of the 5' noncoding region of foot-and-mouth disease virus RNA directs efficient internal initiation of protein synthesis within cells, J. Virol. 64 (1990) 5389-5395 [PubMed].
  27. Belsham G.J., Bustock C.J., Studies on the infectivity of foot-and-mouth disease virus RNA using microinjection, J. Gen. Virol. 69 (1988) 265-274 [PubMed].
  28. Berinstein A., Roivainen M., Hovi T., Mason P.W., Baxt B., Antibodies to the vitronectin receptor (integrin $\alpha_{\rm v}\beta_3$) inhibit binding and infection of foot-and-mouth disease virus to cultured cells, J. Virol. 69 (1995) 2664-2666 [PubMed].
  29. Bienz K., Egger D., Troxler M., Pasamontes L., Structural organization of poliovirus RNA replication is mediated by viral proteins of the P2 region, J. Virol. 64 (1990) 1156-1163 [PubMed].
  30. Bittle J.L., Houghten R.A., Alexander H., Shinnick T.M., Sutcliffe J.G., Lerner R.A., Rowlands D.J., Brown F., Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence, Nature 298 (1982) 30-33 [CrossRef] [PubMed].
  31. Blanco E., McCullough K., Summerfield A., Fiorini J., Andreu D., Chiva C., Borrás E., Barnett P., Sobrino F., Interspecies MHC-restricted Th cell epitope on foot-and-mouth disease virus capsid protein VP4, J. Virol. 74 (2000) 4902-4907 [CrossRef] [PubMed].
  32. Bolwell C., Brown A.L., Barnett P.V., Campbell R.O., Clarke B.E., Parry N.R., Ouldridge E.J., Brown F., Rowlands D.J., Host cell selection of antigenic variants of foot-and-mouth disease virus, J. Gen. Virol. 70 (1989) 45-57 [PubMed].
  33. Borca M.V., Fernández F., Sadir A.M., Braun M., Schudel A.A., Immune response to foot-and-mouth disease virus in a murine model: effective thymus-independent primary and secondary reaction, Immunology 59 (1988) 261-267.
  34. Briand J.P., Benkirane, N., Guichard G., Newman J.F.E., van Regenmortel M.H.V., Brown F., Muller S., A retro-inverso peptide corresponding to the GH loop of foot-and-mouth disease virus elicits high levels of long-lasting protective neutralizing antibodies, Proc. Natl. Acad. Sci. USA 94 (1997) 12545-12550 [CrossRef] [PubMed].
  35. Brooksby J.B., Proceedings of the International Symposium on Foot-and-mouth disease, Symp. Ser. Immunobiol. Stand. 8 (1968) 1-10.
  36. Brooksby J.B., Portraits of viruses: Foot-and-mouth disease virus, Intervirology 18 (1982) 1-23 [PubMed].
  37. Brown F., Structure-function relationships in the picornaviruses, in: Pérez-Bercoff R. (Ed.), The molecular biology of picornaviruses, Plenum Press, New York, 1977, pp. 49-72.
  38. Brown F., Use of peptides for immunization against foot and mouth disease, Vaccine 6 (1988) 180-183 [CrossRef] [PubMed].
  39. Brown F., New approaches to vaccination against foot-and-mouth disease, Vaccine 10 (1992) 1022-1026 [CrossRef] [PubMed].
  40. Brown F., Antibody recognition and neutralization of foot-and-mouth disease virus, Semin. Virol. 6 (1995) 243-248 [CrossRef].
  41. Brown F., Newman J.F.E., Scott J., Porter A., Frisby D., Newton C., Carey N., Fellner P., Poly (C) in animal virus RNAs, Nature 251 (1974) 342-344 [CrossRef] [PubMed].
  42. Burrows R., Studies on the carrier state of cattle exposed to foot-and-mouth disease virus, J. Hyg. 64 (1966) 81-90.
  43. Burrows R., Mann J.A., Garland A.J., Greig A., Goodridge D., The pathogenesis of natural and simulated natural foot-and-mouth disease infection in cattle, J. Comp. Pathol. 91 (1981) 599-609 [CrossRef] [PubMed].
  44. Cao X., Bergmann I.E., Beck E., Comparison of the 5' and 3' untranslated genomic regions of virulent and attenuated foot-and-mouth disease viruses (strains O1 Campos and C3 Resende), J. Gen. Virol. 72 (1991) 2821-2825 [PubMed].
  45. Carrillo C., Plana J., Mascarella R., Bergadá J., Sobrino F., Genetic and phenotypic variability during replication of foot-and-mouth disease virus in swine, Virology 179 (1990) 890-892 [CrossRef] [PubMed].
  46. Carrillo C., Borca M., Moore D.M., Morgan D.O., Sobrino F., In vivo analysis of the stability and fitness of variants recovered from foot-and-mouth disease virus quasispecies, J. Gen. Virol. 79 (1998) 1699-1706 [PubMed].
  47. Carrillo C., Wigdorovitz A., Oliveros J.C., Zamorano P.I., Sadir A.M., Gómez N., Salinas J., Escribano J.M., Borca M.V., Protective immune response to foot-and-mouth disease virus with VP1 expressed in transgenic plants, J. Virol. 72 (1998) 1688-1690 [PubMed].
  48. Chatterjee N.K., Polatnick J., Bachrach H.L., Cell-free translation of foot-and-mouth disease virus RNA into identifiable noncapsid and capsid proteins, J. Gen. Virol. 32 (1976) 383-394 [PubMed].
  49. Cheung A.K., Küpper H., Biotechnological approach to a new foot-and-mouth disease vaccine, Biotechnol. Genet. Eng. Rev. 1 (1984) 223-259 [PubMed].
  50. Childerstone A.J., Cedillo-Baron J., Foster-Cuevas R., Parkhouse M.E., Demonstration of bovine CD8+ T-cell responses to foot-and-mouth disease virus, J. Gen. Virol. 80 (1999) 663-669 [PubMed].
  51. Chinsangaram J., Beard C., Mason P.W., Zellner M.K., Ward G., Grubman M.J., Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins, J. Virol. 72 (1998) 4454-4457 [PubMed].
  52. Chow M., Newman J.F.E., Felman D., Hogle J.M., Rowlands D.J., Brown F., Myristylation of picornavirus capsid protein VP4 and its structural significance, Nature 237 (1987) 482-486 [CrossRef].
  53. Clarke B.E., Brown A.L., Currey K.M., Newton S.F., Rowlands D.J., Carroll A.R., Potential secondary and tertiary structure in the genomic RNA of foot-and-mouth disease virus, Nucleic Acids Res. 15 (1987) 7067-7079 [CrossRef] [PubMed].
  54. Clarke B.E., Newton S.E., Carroll A.R., Francis M.J., Appleyard G., Syred A.D., Highfield P.E., Rowlands D.J., Brown F., Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein, Nature 330 (1987) 381-384 [CrossRef] [PubMed].
  55. Collen T., Foot-and-mouth disease virus (aphthovirus): viral T cell epitopes, in: Goddeevis B.M.L., Morrison I. (Eds.), Cell mediated immunity in ruminants, CRC Press Inc, Boca Raton, 1994, pp. 173-197.
  56. Collen T., Doel T.R., Heterotypic recognition of foot-and-mouth disease virus by cattle lymphocytes, J. Gen. Virol. 71 (1990) 309-315 [PubMed].
  57. Collen T., Pullen L., Doel T.R., T Cell dependent induction of antibody against foot-and-mouth disease virus in a mouse model, J. Gen. Virol. 70 (1989) 395-403 [PubMed].
  58. Collen T., DiMarchi R., Doel T.R., A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle, J. Immunol. 146 (1991) 749-755 [PubMed].
  59. Collen T., Baron J., Childerstone A., Corteyn A., Doel T.R., Flint M., García-Valcarcel M., Parkhouse R.M.E., Ryan M.D., Heterotypic recognition of recombinant FMDV proteins by bovine T-cells: the polymerase (P3Dpol) as an immunodominant T-cell immunogen, Virus Res. 56 (1998) 125-133 [CrossRef] [PubMed].
  60. Cowan K.M., Graves J.H., A third antigenic component associated with foot-and-mouth disease virus, Virology 30 (1966) 528-540 [CrossRef] [PubMed].
  61. Cox S.J., Barnett P.V., Dani P., Salt J.S., Emergency vaccination of sheep against foot-and-mouth disease: protection against disease and reduction in contact transmission, Vaccine 17 (1999) 1858-1868 [CrossRef] [PubMed].
  62. Curry S., Fry E., Blakemore W., Abu-Ghazaleh R., Jackson T., King A., Lea S., Newman J., Rowlands D., Stuart D., Perturbations in the surface structure of A22 Iraq foot-and-mouth disease virus accompanying coupled changes in host cell specificity and antigenicity, Structure 4 (1996) 135-145 [CrossRef] [PubMed].
  63. Dawe P.S., Flanagan F.O., Madekurozwa R.L., Sorensen K.J., Anderson E.C., Foggin C.M., Ferris N.P., Knowles N.J., Natural transmission of foot-and-mouth disease virus from African buffalo (Syncerus caffer) to cattle in a wildlife area of Zimbabwe, Vet. Rec. 134 (1994) 230-232 [PubMed].
  64. de Diego M., Brocchi E., Mackay D., de Simone F., The non-structural polyprotein 3ABC of foot-and-mouth disease virus as a diagnostic antigen in ELISA to differentiate infected from vaccinated cattle, Arch. Virol. 142 (1997) 2021-2033 [CrossRef] [PubMed].
  65. de la Torre J.C., Dávila M., Sobrino F., Ortín J., Domingo E., Establishment of cell lines persistently infected with foot-and-mouth disease virus, Virology 145 (1985) 24-35 [CrossRef] [PubMed].
  66. de la Torre J.C., Martínez-Salas E., Díez J, Villaverde A., Gebauer F., Rocha E., Dávila M., Domingo E., Coevolution of cells and viruses in a persistent infection of foot-and-mouth disease virus in cell culture, J. Virol. 62 (1988) 2050-2058 [PubMed].
  67. Devaney M.A., Vakharia V.N., Lloyd R.E., Ehrengeld E., Grubman M.J., Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex, J. Virol. 62 (1988) 4407-4409 [PubMed].
  68. Díez J., Mateu M.G., Domingo E., Selection of antigenic variants of foot-and-mouth disease virus in the absence of antibodies, as revealed by an "in situ" assay, J. Gen. Virol. 70 (1989) 3281-3289 [PubMed].
  69. Díez J., Dávila M., Escarmis C., Mateu M.G., Domínguez J., Pérez J.J., Giralt E., Melero J.A., Domingo E., Unique amino acid substitutions in the capsid proteins of foot-and-mouth disease virus from a persistent infection in cell culture, J. Virol. 64 (1990) 5519-5528 [PubMed].
  70. DiMarchi R., Brooke G., Gale C., Cracknell V., Doel T.J., Mowat W., Protection of cattle against foot-and-mouth disease by a synthetic peptide, Science 232 (1986) 639-641 [CrossRef].
  71. Doedens J.R., Kirkegaard K., Inhibition of cellular protein secretion by poliovirus proteins 2B and 3A, EMBO J. 14 (1995) 894-907 [PubMed].
  72. Doel T.R., Optimisation of the immune response to foot-and-mouth disease vaccines, Vaccine 17 (1999) 1767-1771 [CrossRef] [PubMed].
  73. Doel T.R., Doel C.M.F.A., Staple R.F., DiMarchi R., Cross-reactive and serotype-specific antibodies against foot-and-mouth disease virus generated by different regions of the same synthetic peptide, J. Virol. 66 (1992) 2187-2194 [PubMed].
  74. Doel T.R., Williams L., Barnett. P.V., Emergency vaccination against foot-and-mouth disease: rate of development of immunity and its implications for the carrier state, Vaccine 12 (1994) 592-600 [CrossRef] [PubMed].
  75. Domingo E., Viruses at the edge of adaptation, Virology 270 (2000) 251-253 [CrossRef] [PubMed].
  76. Domingo E., Holland J.J., RNA virus mutations and fitness for survival, Annu. Rev. Microbiol. 51 (1997) 151-178 [PubMed].
  77. Domingo E., Dávila M., Ortín J., Nucleotide sequence heterogeneity of the RNA from a natural population of foot-and-mouth disease virus, Gene 11 (1980) 333-346 [CrossRef] [PubMed].
  78. Domingo E., Martínez-Salas E., Sobrino F., de la Torre J.C., Portela A., Ortín J., López-Galindez C., Pérez-Breña P., Villanueva N., Nájera R., VandePol S., Steinhauner D., de Polo N., Holland J.J., The quasispecies (extremely heterogeneous) nature of viral RNA genome populations, biological relevance - a review, Gene 40 (1985) 1-8 [CrossRef].
  79. Domingo E., Mateu M.G., Martínez M.A., Dopazo J., Moya A., Sobrino F., Genetic variability and antigenic diversity of foot-and-mouth disease virus, in: Kurstak E., Marusyk R.G., Murphy S.A., Van-Regenmortel M.H.V. (Eds.), Applied virology research, Vol. 2, Virus variation and epidemiolgy, Plenum Publishing Corp., New York, 1990, pp. 233-266.
  80. Domingo E., Escarmís C., Martínez M.A., Martínez-Salas E., Mateu M.G., Foot-and-mouth disease virus populatons are quasispecies, Curr. Top. Microbiol. Immunol. 176 (1992) 33-47 [PubMed].
  81. Domingo E., Díez J., Martínez M.A., Hernández J., Holguín A., Borrego B., Mateu M.G., New observations on antigenic diversification of RNA viruses. Antigenic variation is not dependent on immune selection, J. Gen. Virol. 74 (1993) 2039-2045 [PubMed].
  82. Domingo E., Mateu M.G., Escarmís C., Martínez-Salas E., Andreu D., Giralt E., Verdaguer N., Fita I., Molecular evolution of aphthoviruses, Virus Genes 11 (1996) 197-207 [CrossRef].
  83. Donaldson A.I., Doel T.R., Foot-and-mouth disease: the risk for Great Britain after 1992, Vet. Rec. 131 (1992) 114-117 [PubMed].
  84. Donaldson A.I., Gibson C.F., Oliver R., Hamlin C., Kitching R.F., Infection of cattle by airborne foot-and-mouth disease virus: minimal doses with O2 and SAT2 strains, Res. Vet. Sci. 43 (1987) 339-346 [PubMed].
  85. Dopazo J., Sobrino F., Palma E.L., Domingo E., Moya A., Gene encoding capsid protein VP1 of foot-and-mouth disease virus: a quasispecies model of molecular evolution, Proc. Natl. Acad. Sci. USA 85 (1988) 6811-6815 [CrossRef] [PubMed].
  86. Dopazo J., Rodrigo M.J., Rodríguez A., Sáiz J.C., Sobrino F., Aphthovirus evolution, in: Gibbs A., Calisher C.H. (Eds.), Molecular evolution of viruses, Cambridge University Press, Cambridge, 1994, pp. 310-320.
  87. Eigen M., Schuster P., The hypercycle: a principle of natural self-organization, Springer-Verlag, Berlin, Heidelberg, New York, 1979.
  88. Escarmís C., Dopazo J., Dávila M., Palma E.L., Domingo E., Large deletions in the 5'-untraslated region of foot-and-mouth disease virus of serotype C, Virus Res. 35 (1995) 155-167 [CrossRef] [PubMed].
  89. Escarmís C., Dávila M., Charpentier N., Bracho A., Moya A., Domingo E., Genetic lesions associeted with Muller's ratchet in an RNA virus, J. Mol. Biol. 164 (1996) 255-267 [CrossRef].
  90. Escarmís C., Carrillo E.C., Ferrer M., Arriaza J.F., Lopez N., Tami C., Verdaguer N., Domingo E., Franze-Fernandez M.T., Rapid selection in modified BHK-21 cells of a foot-and-mouth disease virus variant showing alterations in cell tropism, J. Virol. 72 (1998) 10171-10179 [PubMed].
  91. Falk M.M., Grigera P.R., Bergman I.E., Zibert A., Multhaup G., Beck E., Foot-and-mouth disease virus protease 3C induces specific proteolytic cleavage of host cell histone H3, J. Virol. 64 (1990) 748-756 [PubMed].
  92. Falk M.M., Sobrino F., Beck E., VPg gene amplification correlates with infective particle formation in foot-and-mouth disease virus, J. Virol. 66 (1992) 2251-2260 [PubMed].
  93. Feigelstock M.G., Mateu M.G., Piccone M.E., De Simone F., Brocchi E., Domingo E., Palma E.L., Extensive antigenic diversification of foot-and-mouth disease virus by amino acid substitutions outside the major antigenic site, J. Gen. Virol. 73 (1992) 3307-3311 [PubMed].
  94. Forss S., Schaller H., A tandem repeat gene in a picornavirus, Nucleic Acids Res. 10 (1982) 6441-6445 [CrossRef] [PubMed].
  95. Fox G., Parry N.R., Barnett P.V., McGinn B., Rowlands D.J., Brown F., The cell attachment site of foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid), J. Gen. Virol. 70 (1989) 625-637 [PubMed].
  96. Fracastorius H., De contagione et contagiosis morbis et curatione, Book 1, Chapter 12, Venecia, 1546.
  97. Francis M.J., Black L., Antibody response in pig nasal fluid and serum following foot-and-mouth disease infection or vaccination, J. Hyg. 91 (1983) 329-343.
  98. Francis M.J., Hastings G.Z., Syred A.D., McGinn B., Brown F, Rowlands D.J., Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants, Nature 330 (1987) 168-170 [CrossRef] [PubMed].
  99. Francis M.J., Hastings G.Z., Clarke B.E., Brown A.L., Beddell C.R., Rowlands D.J., Brown F. Neutralizing antibodies to all seven serotypes of foot-and-mouth disease virus elicited by synthetic peptides, Immunology 69 (1990)171-176.
  100. Fry E.E., Lea S.M., Jackson T., Newman J.W., Ellard F.M., Blakemore W.E., Abu-Ghazaleh R., Samuel A., King A.M., Stuart D.I., The structure and function of a foot-and-mouth disease virus- oligosaccharide receptor complex, EMBO J. 18 (1999) 543-554 [CrossRef] [PubMed].
  101. García-Briones M.M., Russell G., Carrillo E., Palma E.L., Taboga O., Tami C., Sobrino F., Glass E.J., Association of bovine DRB3 alleles with the immune response to foot-and-mouth disease virus peptides and protection against viral chalenge, Vaccine (in press).
  102. García-Valcarcel M., Doel T., Collen T., Ryan M., Parkhouse M.E., Recognition of foot-and-mouth disease virus and its capsid protein VP1 by bovine peripheral T lymphocytes, J. Gen. Virol. 77 (1996) 727-735 [PubMed].
  103. Gebauer F., de la Torre J.C., Gomes I., Mateu M.G., Barahona H., Tiraboschi B., Bergmann I., Augé de Mello P., Domingo E., Rapid selection of genetic and antigenic variants of foot-and-mouth disease virus during persistence in cattle, J. Virol. 62 (1988) 2041-2049 [PubMed].
  104. Glass E.J., Millar P., Induction of effective cross-reactive immunity by FMDV peptides is critically dependent upon specific MHC-peptide-T cell interactions, Immunology 82 (1994) 1-8 [PubMed].
  105. Glass E.J., Millar P., Bovine T cells preferentially recognize non-viral spacer epitopes in a putative FMDV vaccinal peptide, Vaccine 13 (1995) 225-229 [CrossRef] [PubMed].
  106. Glass E.J., Oliver R.A., Collen T., Doel T.R., DiMarchi R., Spooner R.L., MHC Class II restricted recognition of FMDV peptides by bovine T cells, Immunology 74 (1991) 594-599 [PubMed].
  107. González M., Mateu M., Martínez M.A., Carrillo C., Sobrino F., Comparison of capsid protein VP1 of the viruses used for the production and challenge of foot-and-mouth disease vaccines in Spain, Vaccine 10 (1992) 731-734 [CrossRef] [PubMed].
  108. Gras-Masse H., Boutillon C., Diesis E., Deprez B., Tartar A., Confronting the degeneracy of convergent combinatorial immunogens, or "mixotopes", with the specificity of recognition of the target sequences, Vaccine 15 (1997) 1568-1578 [CrossRef] [PubMed].
  109. Gromeier M., Wimmer E., Gorbalenya A.E., Genetics, pathogenesis and evolution of picornaviruses, in: Domingo E., Webster R., Holland J. (Eds.), Origin and evolution of viruses, Academic Press, 1999, pp. 287-343.
  110. Grubman M.J., Morgan D.O., Kendall J., Baxt B., Capsid intermediates assembled in a foot-and-mouth disease genome RNA-programmed cell-free translation system and in infected cells, J. Virol. 56 (1985) 120-126 [PubMed].
  111. Grubman M.J., Lewis S.A., Morgan D.O., Protection of swine against foot-and-mouth disease with viral capsid proteins expressed in heterologous systems, Vaccine 11 (1993) 825-829 [CrossRef] [PubMed].
  112. Gutiérrez A., Martínez-Salas E., Pintado B., Sobrino F., Specific inhibition of aphthovirus infection by RNAs transcribed from both 5' and 3' noncoding region, J. Virol. 68 (1994) 7426-7432 [PubMed].
  113. Hamblin C., Barnett I.T.R., Hedger R., A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. I. Development and method of ELISA, J. Immunol. Methods 93 (1986) 115-118 [CrossRef] [PubMed].
  114. Harris T.J.R., Brown F., Biochemical analyses of a virulent and an avirulent strain of foot-and-mouth disease virus, J. Gen. Virol. 34 (1977) 87-105 [PubMed].
  115. Hedger R.S., Condy J.B., Transmission of foot-and-mouth disease from African buffalo virus carriers to bovine, Vet. Rec. 17 (1985) 205.
  116. Hogle J.M., Chow M., Filman D.J., Three-dimensional structure of poliovirus at 2.9 A resolution, Science 229 (1985) 1358-1365 [CrossRef].
  117. Holland J., Spindler K., Horodyski F., Grabau E., Nichol S., VandePol S., Rapid evolution of RNA genomes, Science 215 (1982) 1577-1585 [CrossRef].
  118. Jackson T., Ellard F.M., Ghazaleh R.A., Brookes S.M., Blakemore W.E., Corteyn A.H., Stuart D.I., Newman J.W., King A.M.Q., Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate, J. Virol. 70 (1996) 5282-5287 [PubMed].
  119. Jackson T., Sharma A., Ghazaleh R.A., Blakemore W.E., Ellard F.M., Simmons D.L., Newman J.W., Stuart D.I., King A.M.Q., Arginine-glycine-aspartic acid-specific binding by foot-and-mouth disease viruses to the purified integrin $\alpha_{\rm v}\beta_3$ in vitro, J. Virol. 71 (1997) 8357-8361 [PubMed].
  120. Jackson T., Blakemore W., Newman J.W., Knowles N.J., Mould A.P., Humphries M.J., King A.M.Q., Foot-and-mouth disease virus is a ligand for the high-affinity binding conformation of integrin $\alpha_{\rm v}\beta_1$: influence of the leucine residue within the RGDL motif on selectivity of integrin binding, J. Gen. Virol. 81 (2000) 1382-1391.
  121. Jackson T., Sheppard D., Denyer M., Blakemore W., King A.M.Q., The epithelial integrin $\alpha_{\rm v}\beta_6$ is a receptor for foot-and-mouth disease virus, J. Virol. 74 (2000) 4949-4956 [CrossRef] [PubMed].
  122. King A.M.Q., Genetic recombination in positive strand RNA viruses, in: Domingo E., Holland J.J., Ahlquist P. (Eds.), RNA genetics, Vol. II, Retroviruses, Viroids, and RNA recombination, CRC Press, Boca raton, Florida, 1988, pp. 149-166.
  123. King A.M.Q., Sangar D.V., Harris T.J.R., Brown F., Heterogeneity of the genome-linked protein of foot-and-mouth disease virus, J. Virol. 34 (1980) 627-634 [PubMed].
  124. King A.M.Q., Underwood B.O., McCahon D., Newman J.W., Brown F., Biochemical identification of viruses causing the 1981 outbreak of foot-and-mouth disease in the UK, Nature 293 (1981) 479-480 [CrossRef] [PubMed].
  125. King A.M.Q., McCahon D., Slade W.R., Newman J.W.I., Recombination in RNA, Cell 29 (1982) 921-928 [CrossRef] [PubMed].
  126. Kitching R.P., A recent history of foot-and-mouth disease virus, J. Comp. Pathol. 118 (1998) 89-108 [PubMed].
  127. Kitching R.P., Rendle R., Ferris N.P., Rapid correlation between field isolates and vaccine strains of foot-and-mouth disease virus, Vaccine 6 (1988) 403-408 [CrossRef] [PubMed].
  128. Kitching R.P., Knowles N.J., Samuel A.R., Donaldson A.I., Development of foot-and-mouth disease virus strain characterization - a review, Trop. Anim. Health Prod. 21 (1989) 153-166 [CrossRef] [PubMed].
  129. Kitson J.D.A., McCahon D., Belsham G.J., Sequence analysis of monoclonal antibody resistant mutants of type O foot-and-mouth disease virus: Evidence for the involvement of the three surface exposed capsid protein in four antigenic sites, Virology 179 (1990) 26-34 [CrossRef] [PubMed].
  130. Kleid D.G., Yansura D., Small B., Dowbenko D., Moore D.M., Grubman M.J., McKercher P.D., Morgan D.O., Robertson B.H., Bachrach H.L., Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine, Science 214 (1981) 1125-1129 [CrossRef].
  131. Krebs O., Marquardt O., Identification and characterization of foot-and-mouth disease virus O1 Burgwedel/1987 as an intertypic recombinant, J. Gen. Virol. 73 (1992) 613-619 [PubMed].
  132. Kühn R., Luz N., Beck E., Functional analysis of the internal translation initiation site of foot-and-mouth disease virus, J. Virol. 64 (1990) 4625-4631 [PubMed].
  133. Lai W.C., Bennett M., DNA vaccines, Crit. Rev. Immunol. 18 (1998) 449-484 [PubMed].
  134. Laporte J., Grosclaude J., Wantyghem J., Bernard S., Rouze P., Neutralisation en culture cellulaire du pouvoir infectieux du virus de la fièvre aphteuse par des sérums provenant de porcs immunisés a l'aide d'une protéine virale purifiée, C.R. Hebd. Séances Acad. Sci. Paris 276 (1973) 3390-3401.
  135. Lea S., Hernández J., Blakemore W., Brocchi E., Curry S., Domingo E., Fry E., Abu-Ghazaleh R., King A., Newman J., Stuart D., Mateu M.G., Structure and antigenicity of a type C foot-and-mouth disease virus, Structure 2 (1994) 123-139 [CrossRef] [PubMed].
  136. Lea S., Abu-Ghazaleh R., Blakemore W., Curry S., Fry E., Jackson T., King A., Logan D., Newman J., Stuart D., Structural comparison of two strains of foot-and-mouth disease virus subtype O1 and a laboratory antigenic variant, G67, Structure 3 (1995) 571-580 [CrossRef] [PubMed].
  137. Leippert M., Beck E., Weiland F., Pfaff E., Point mutations within the betaG-betaH loop of foot-and-mouth disease virus O1K affect virus attachment to target cells, J. Virol. 71 (1997) 1046-1051 [PubMed].
  138. Lewis S.A., Morgan D.O., Grubman M.J., Expression, processing and assembly of foot-and-mouth disease virus capsid proteins in heterologous systems: induction of a neutralizing antibody response in guinea pigs, J. Virol. 65 (1991) 6572-6580 [PubMed].
  139. Loeffler F., Frosch P., Summarischer bericht uber die ergebnisse der untersuchungen der kommoission zur erforchung der maul-und-klamenseuche, Zentralbl. Bakteriol. Parasitenk. Infektionskr. 22 (1897) 257-259.
  140. Logan D., Abu-Ghazaleh R., Blakemore W., Curry S., Jackson T., King A., Lea S., Lewis R., Newman J., Parry N., Rowlands D., Stuart D., Fry E., Structure of a major immunogenic site on foot-and-mouth disease virus, Nature 362 (1993) 566-568 [CrossRef] [PubMed].
  141. López de Quinto S., Martínez-Salas E., Conserved structural motifs located in distal loops of aphtovirus internal ribosome entry site domain 3 are required for internal initiation of translation, J. Virol. 71 (1997) 4174-4175.
  142. Lubroth J., Brown F., Identification of native foot-and-mouth disease virus non-structural protein 2C as a serological indicator to differentiate infected from vaccinated livestock, Res. Vet. Sci. 59 (1995) 70-78 [CrossRef] [PubMed].
  143. Mackay D.K.J., Forsyth M.A., Davies P.R., Berlinzani A., Belsham G., Flint M., Ryan M.D., Differentiating infection from vaccination in foot-and-mouth disease using a panel of recombinant, non-structural proteins in ELISA, Vaccine 16 (1988) 446-459 [CrossRef].
  144. Marquardt O, Haas B., Sequences of capsid protein VP1 of two type A foot-and-mouth disease virus, Virus Genes 2 (1988) 185-193.
  145. Martín M.J., González-Candelas F., Sobrino F., Dopazo J., A method for determining the position and size of optimal sequence regions for phylogenetic analysis, J. Mol. Evol. 41 (1995) 1128-1138 [PubMed].
  146. Martín M.J., Núñez J.I., Sobrino F., Dopazo J., A procedure for detecting selection in viral genomes: evidence of positive selection in antigenic regions of foot-and-mouth disease virus capsid protein VP1, J. Virol. Methods (1998) 215-221.
  147. Martínez M.A., Carrillo C., Plana J., Mascarella R., Bergadá J., Palma E.L., Domingo E., Sobrino F., Genetic and immunogenic variations among closely related isolates of foot-and-mouth disease virus, Gene 62 (1988) 75-84 [CrossRef] [PubMed].
  148. Martínez M.A., Carrillo C., González-Candelas F., Moya A., Domingo E., Sobrino F., Fitness alteration of foot-and-mouth disease virus mutants: measurement of the adaptability of viral quasispecies, J. Virol. 65 (1991) 3954-3957 [PubMed].
  149. Martínez M.A., Dopazo J., Hernández J., Mateu M.G., Sobrino F., Domingo E., Knowles N.J., Evolution of capsid protein genes of foot-and-mouth disease virus: antigenic variation without accumulation of amino acid substitutions over six decades, J. Virol. 66 (1992) 3557-3565 [PubMed].
  150. Martínez M.A., Verdaguer N., Mateu M.G., Domingo E., Evolution subverting essentiality: dispensability of the cell attachment Arg-Gly-Asp motif in multiple passaged foot-and-mouth disease virus, Proc. Natl. Acad. Sci. USA 94 (1997) 6798-6802 [CrossRef] [PubMed].
  151. Martínez-Salas E., Internal ribosome entry site biology and its use in expression vectors, Curr. Opin. Biotechnol. 10 (1999) 458-464 [CrossRef] [PubMed].
  152. Martínez-Salas E., Regalado M.P., Domingo E., Identification of an essential domain for internal initiation of translation in the aphtovirus internal ribosome entry site and implications for viral evolution, J. Virol. 70 (1996) 992-998 [PubMed].
  153. Mason P.W, Baxt B., Brown F., Harber J., Murdin A., Wimmer E., Antibody-complexed foot-and-mouth disease virus, but not poliovirus, can infect normally insusceptible cells via the Fc receptor, Virology 192 (1993) 568-577 [CrossRef] [PubMed].
  154. Mason P.W., Rieder E., Baxt B., RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway, Proc. Natl. Acad. Sci. USA 91 (1994) 1932-1936 [CrossRef] [PubMed].
  155. Mason P.W., Piccone M.E., McKenna T.S.C., Chinsangaram J., Grubman M.J., Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate, Virology 227 (1997) 96-102 [CrossRef] [PubMed].
  156. Mateu M.G., Antibody recognition of picornaviruses and escape from neutralization: a structural view, Virus Res. 38 (1995) 1-24 [CrossRef] [PubMed].
  157. Mateu M.G., da Silva J.L., Rocha E., de Brum D.L., Alonso A., Enjuanes L., Domingo E., Barahona H., Extensive antigenic heterogeneity of foot-and-mouth disease virus of serotype Cl, Virology 167 (1988) 113-124 [CrossRef] [PubMed].
  158. Mateu M.G., Martínez M.A., Rocha E., Andreu D., Parejo J., Giralt E., Sobrino F., Domíngo E., Implication of a quasispecies genome structure: effect of frequent, naturally occurring amino acid substitutions on the antigenicity of foot-and-mouth disease virus, Proc. Natl. Acad. Sci. USA 86 (1989) 5883-5887 [CrossRef] [PubMed].
  159. Mateu M.G., Martínez M.A., Capucci L., Andreu D., Giralt E., Sobrino F., Brocchi E., Domingo E., A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C, J. Gen. Virol. 71 (1990) 629-637 [PubMed].
  160. Mateu M.G., Valero M.L., Andreu D., Domingo E., Systematic replacement of amino acid residues within an Arg-Gly-Asp-containing loop of foot-and-mouth disease virus and effect on cell recognition, J. Biol. Chem. 271 (1996) 12814-12819 [CrossRef] [PubMed].
  161. McCullough K.C., de Simone F., Brocchi E., Capucci L., Crowther J.R., Kihm U., Protective immune response against foot-and-mouth disease virus, J. Virol. 66 (1992) 1835-1840 [PubMed].
  162. McKenna T.S.C., Lubroth J., Rieder E., Baxt B., Mason P.W., Receptor binding site-deleted foot-and-mouth disease (FMD) virus protects cattle from FMD, J. Virol. 69 (1995) 5787-5790 [PubMed].
  163. Meloen R.H., Barteling S.J., An epitope located at the C-terminus of isolated VP1 of foot-and-mouth disease virus O induces neutralizing activity but poor protection, J. Gen. Virol. 67 (1986) 289-294 [PubMed].
  164. Meyer K., Petersen A., Niepmann M., Beck E., Interaction of eukaryotic initiation factor eIF-4B with a picornavirus internal translation initiation site, J. Virol. 69 (1995) 2819-2824 [PubMed].
  165. Meyer R.F., Brown C.C., House C., House J.A., Molitor T.W., Rapid and sentitive detection of foot-and-mouth disease virus in tissues by enzymatic RNA amplification of the polymerase gene, J. Virol. Methods 34 (1991) 161-172 [CrossRef] [PubMed].
  166. Mulcahy G., Gale C., Robertson P., Iyisan S., DiMarchi R.D., Doe T.R., Isotype responses of infected virus-vaccinated and peptide-vaccinated cattle to foot-and-mouth disease virus, Vaccine 8 (1990) 249-256 [CrossRef] [PubMed].
  167. Neff S., Sa-Carvalho D., Rieder E., Mason P.W., Blystone S.D., Brown E.J., Baxt B., Foot-and-mouth disease virus virulent for cattle utilizes the integrin $\alpha_{\rm v}\beta_3$ as its receptor, J. Virol. 72 (1998) 3587-3594 [PubMed].
  168. Neitzert E., Beck E., Auge de Mello P., Gomes Y, Bergmann I., Expression of the aphtovirus RNA polymerase gene in E. coli and its use together with other bioengineered nonstructural antigens in detection of late persistent infections, Virology 184 (1991) 799-804 [CrossRef] [PubMed].
  169. Newman J.F.E., Cartwright B., Doel T.R., Brown F., Purification and identification of the RNA-dependent RNA polymerase of foot-and-mouth disease virus, J. Gen. Virol. 45 (1979) 497-507 [PubMed].
  170. Newman J.F.E., Piatti P.G., Gorman B.M., Burrage T.G., Ryan M.D., Flint M., Brown F., Foot-and-mouth disease virus particles contain replicase protein 3D, Proc. Natl. Acad. Sci. USA 91 (1994) 733-737 [CrossRef] [PubMed].
  171. Niepmann M., Petersen A., Meyer K., Beck E., Functional involvement of polypyrimidine tract-binding protein in translation initiation complexes with the internal ribosome entry site of foot-and-mouth disease virus, J. Virol. 71 (1997) 8330-8339 [PubMed].
  172. Nuñez J.I., Blanco E., Hernández T., Gómez-Tejedor C., Martín M.J., Dopazo J., Sobrino F., A RT-PCR assay for the differential detection of viral vesicular diseases in swine, J. Virol. Methods 72 (1998) 227-235 [CrossRef] [PubMed]. [172'] Office International des Epizooties, World Organisation for Animal Health. Foot and mouth disease, in: OIE Standards Commission (Ed.), Manual of standards for diagnostic tests and vaccines, 3rd ed., Office International des Epizooties, Paris, France, 1996, Chapter 2.1.1, pp. 47-56.
  173. Pattnaik B., Venkataramanan R., Tosh C., Sanyal A., Hemadari D., Samuel A.R., Knowles N.J., Kitching R.P., Genetic heterogenetity of Indian field isolates of foot-and-mouth disease virus serotype O as revealed by partial sequencing of 1D gene, Virus Res. 55 (1998) 115-127 [CrossRef] [PubMed].
  174. Pereira H.G., Subtyping of foot-and-mouth disease virus, Dev. Biol. Stand. 35 (1977) 167-174.
  175. Pereira H.G., Foot-and-mouth disease, in: Gibbs E.P.J. (Ed.), Virus disease of food animals, Academic Press Inc., London, 1981, pp. 333-363.
  176. Pfaff E., Mussgay M., Bóhm H.O., Schultz G.E., Schaller H., Antibodies against a preselected peptide recognize and neutralize foot-and-mouth disease virus, EMBO J. 1 (1982) 869-874 [PubMed].
  177. Pfaff M., Recognition sites of RGD-dependent integrins, in: Eble J.A., Kühn K. (Eds.), Integrin-Ligand Interaction, Springer-Verlag, Heidelberg, 1997, pp. 101-121.
  178. Piccone M.E., Rieder E., Mason P.W., Grubman M.J., The foot-and-mouth disease virus leader proteinase gene is not required for viral replication, J. Virol. 69 (1995) 5376-5382 [PubMed].
  179. Pinto A.A., Garland A.J.M., Immune response to virus-infection-associated (VIA) antigen in cattle repeatedly vaccinated with foot-and-mouth inactivated by formalin or acetylethyleneimine, J. Hyg. 82 (1979) 41-50.
  180. Polatnick J., Isolation of a foot-and-mouth disease virus polyuridylic acid polymerase and its inhibition by antibodies, J. Virol. 33 (1980) 774-779 [PubMed].
  181. Porter A.G., Picornavirus nonstructural proteins: emerging roles in virus replication and inhibition of host cell functions, J. Virol. 67 (1993) 6917-6921 [PubMed].
  182. Reid S.M., Hutchings G.H., Ferris N.P., de Clercq K., Diagnosis of foot-and-mouth disease virus by RT-PCR: evaluation of primers for serotypic characterisation of viral RNA in clinical samples, J. Virol. Methods 83 (1999) 113-123 [CrossRef] [PubMed].
  183. Rieder E., Bunch T., Brown F., Mason P.W., Genetically engineered foot-and-mouth disease virus with poly (C) tracts of two nucleotides are virulent in mice, J. Virol. 67 (1993) 5139-5145 [PubMed].
  184. Rieder E., Berinstein A., Baxt B., Kang A., Mason P.W., Propagation of an attenuated virus by design: engineering a novel receptor for a noninfectious foot-and-mouth disease virus, Proc. Natl. Acad. Sci. USA 93 (1996) 10428-10433 [CrossRef] [PubMed].
  185. Rodrigo M.J., Dopazo J., Evolutionary analysis of picornavirus family, J. Mol. Evol. 39 (1994) 3662-3671.
  186. Rodríguez A., Martínez-Salas E., Dopazo J., Dávila M., Sáiz J.C., Sobrino, F., Primer design for specific diagnosis by PCR of highly variable RNA viruses: typing of foot-and-mouth disease virus, Virology 189 (1992) 363-367 [CrossRef] [PubMed].
  187. Rodríguez A., Dopazo J., Sáiz J.C., Sobrino F., Immunogenicity of non-structural proteins of foot-and-mouth disease virus: differences between infected and vaccinated swine, Arch. Virol. 136 (1994) 123-131 [CrossRef] [PubMed].
  188. Rodríguez A., Núñez J.I., Nolasco G., Ponz F., Sobrino F., de Blas C., Direct PCR detection of foot-and-mouth disease virus, J. Virol. Methods 47 (1994) 345-349 [CrossRef] [PubMed].
  189. Rodríguez A., Sáiz J.C., Nonbela I.S., Andreu D., Sobrino F., Antigenic specificity of porcine T cell response against foot-and-mouth disease virus structural proteins. Identification of T helper epitopes in VP1, Virology 206 (1994) 24-33 [CrossRef].
  190. Rodríguez A., Ley V., Ortúño E., Ezquerra A., Saalmüller A., Sobrino F., Sáiz J.C., A porcine CD8+ T cell clone with heterotypic specificity to foot-and-mouth disease virus, J. Gen. Virol. 77 (1996) 2089-2096 [PubMed].
  191. Roeder P.L., Le Blanc Smith P.M., Detection and typing of foot-and-mouth disease virus by enzyme linked immunosorbent assay: a sensitive, rapid and reliable technique for primary diagnosis, Res. Vet. Sci. 45 (1987) 225-230.
  192. Roosien J., Belsham G.J., Ryan M.D., King A.M.Q., Black J.M., Synthesis of foot-and-mouth disease virus capsid proteins in insect cells using baculovirus expression vectors, J. Gen. Virol. 71 (1990) 1703-1711 [PubMed].
  193. Rossman M.G., The canyon hypothesis, J. Biol. Chem. 264 (1989) 14587-14590 [PubMed].
  194. Rowlands D.J., Experimental determination of immunogenic sites, in: Nicholson B.H. (Ed.), Synthetic Vaccines, Oxford: Blackwell Scientific Publications, 1994, pp. 137-168.
  195. Rowlands D.J., Sangar D.V., Brown F., A comparative chemical and serological study of the full and empty particles of foot-and-mouth disease virus, J. Gen. Virol. 26 (1975) 227-238 [PubMed].
  196. Rowlands D.J., Clarke B.E., Carroll A.R., Brown F., Nicholson B.H., Bittle J.L., Houghten R.A., Lerner R.A., Chemical basis of antigen variation in foot-and-mouth disease virus, Nature 306 (1983) 694-697 [CrossRef] [PubMed].
  197. Rueckert R.R., Picornaviridae and their replication, in: Fields B.N., Knipe D.M. (Eds.), Fields Virology, 2nd ed., Raven Press, New York, 1996, pp. 507-548.
  198. Ruiz-Jarabo C.M., Sevilla N., Dávila M., Gomez-Mariano G., Baranowski E., Domingo E., Antigenic properties and population stability of a foot-and-mouth disease virus with an altered Arg-Gly-Asp receptor-recognition motif, J. Gen. Virol. 80 (1999) 1899-1909 [PubMed].
  199. Ruiz-Jarabo C.M., Arias A., Baranowski E., Escarmís C., Domingo E., Memory in viral quasispecies, J. Virol. 74 (2000) 3543-3547 [CrossRef] [PubMed].
  200. Rweyemamu M.M., Antigenic variation in foot-and-mouth disease: Studies based on the virus neutralization reaction, J. Biol. Stand. 12 (1984) 323-337 [CrossRef] [PubMed].
  201. Ryan M.D., Belsham G.J., King A.M.Q., Specificity of enzyme-substrate interactions in foot-and-mouth disease virus polyprotein processing, J. Virol. 173 (1989) 35-45.
  202. Ryan M.D., King A.M.Q., Thomas G.P., Cleavage of the foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence, J. Gen. Virol. 72 (1991) 2727-2732 [PubMed].
  203. Sa-Carvalho D., Rieder E., Baxt B., Rodarte R., Tanuri A., Mason P.W., Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle, J. Virol. 71 (1997) 5115-5123 [PubMed].
  204. Sagedahl A., Giraudo A.T., Auge de Mello P., Bergmann I.E., La Torre J.L., Scodeller E.A., Biochemical characterization of an aphthovirus type C3 strain Resende attenuated for cattle by serial passages in chicken embryos, Virology 157 (1987) 366-374 [CrossRef] [PubMed].
  205. Sáiz J.C., Rodríguez A., González M., Alonso F., Sobrino F., Heterotypic lymphoproliferative response in pigs vaccinated with foot-and-mouth disease virus, involvement of isolated capsid proteins, J. Gen. Virol. 73 (1992) 2601-2607 [PubMed].
  206. Sáiz J.C., Sobrino F., Dopazo J., Molecular evolution of foot-and-mouth disease virus type O, J. Gen. Virol. 74 (1993) 2281-2285 [PubMed].
  207. Sáiz J.C., Cairo J., Medina M., Zuidema D., Abrams C., Belsham G.J., Domingo E., Vlak J.M., Unprocessed foot-and-mouth disease capsid precursor displays discontinuous epitopes involved in viral neutralization, J. Virol. 68 (1994) 4557-4564 [PubMed].
  208. Salt J.S., The carrier state in foot and mouth disease virus. An immunological review, Br. Vet. J. 149 (1993) 207-223 [PubMed].
  209. Salt J.S., Barnett P.V., Dani P., Williams L., Emergency vaccination of pigs against foot-and-mouth disease: protection against disease and reduction in contact transmission, Vaccine 16 (1998) 746-754 [CrossRef] [PubMed].
  210. Samuel A.R., Knowles N.J., Kitching R.P., Hafez S.M., Molecular analysis of foot-and-mouth disease type O viruses isolated in Saudi Arabia between 1983 and 1995, Epidemiol. Infect. 119 (1997) 381-389 [CrossRef] [PubMed].
  211. Samuel A.R., Knowles N.J., Mackay D.K., Genetic analyses of type O viruses responsible for epidemics of foot-and-mouth disease in North Africa, Epidemiol. Infect. 122 (1999) 529-538 [CrossRef] [PubMed].
  212. Sangar D.V., The replication of picornaviruses, J. Gen. Virol. 45 (1979) 1-13 [PubMed].
  213. Sangar D.V., Rowlands D.J., Harris T.J.R., Brown F., A protein covalently linked to foot-and-mouth disease virus RNA, Nature 268 (1977) 648-650 [CrossRef] [PubMed].
  214. Sangar D.V., Newton S.E., Rowlands D.J., Clarke B.E., All foot-and-mouth disease viruses initiate protein synthesis at two separate AUGs, Nucleic Acids Res. 15 (1987) 3305-3315 [CrossRef] [PubMed].
  215. Sanz-Parra A., Blasco R., Sobrino F., Ley V., Analysis of the B and T cell response in guinea-pigs induced with recombinant vaccinia expressing foot-and-mouth disease virus structural proteins, Arch. Virol. 143 (1998) 389-398 [CrossRef] [PubMed].
  216. Sanz-Parra A., Sobrino F., Ley V., Infection with foot-and-mouth disease virus results in a rapid reduction of MHC Class I surface expression, J. Gen. Virol. 79 (1998) 433-436 [PubMed].
  217. Sanz-Parra A., Jimenez-Clavero M.A., García-Briones M., Blanco E. Sobrino F., Ley V., Recombinant adenovirus expressing the foot-and-mouth disease virus P1 precursor polypeptide induces cellular but not humoral antiviral immunity and partial protection in pigs, Virology 259 (1999) 129-134 [CrossRef] [PubMed].
  218. Sanz-Parra A., Vázquez B., Sobrino F., Cox S.J., Ley V., Salt J., Evidence of partial protection against foot-and-mouth disease in cattle immunised with a recombinant adenovirus vector expressing the precursor polypeptide of FMDV capsid protein (P1), J. Gen. Virol. 80 (1999) 671-679 [PubMed].
  219. Saunders K., King A.M.Q., McCahon D., Newman J.W.I., Slade W.R., Forss S., Recombination and oligonucleotide analysis of guanidine resistant foot-and-mouth disease virus mutants, J. Virol. 56 (1985) 921-929 [PubMed].
  220. Sellers R.F., Quantitative aspects of the spread of foot-and-mouth disease, Vet. Bull. 41 (1971) 431-439.
  221. Sevilla N., Domingo E., Evolution of a persistent aphthovirus in cytolytic infections: partial reversion of phenotypic traits accompanied by genetic diversification, J. Virol. 70 (1996) 6617-6624 [PubMed].
  222. Sevilla N., Ruiz-Jarabo C.M., Gomez-Mariano G., Baranowski E., Domingo E., An RNA virus can adapt to the multiplicity of infection, J. Gen. Virol. 79 (1998) 2971-2980 [PubMed].
  223. Silberstein E., Kaplan G., Taboga O., Duffy S., Palma E.L., Foot-and-mouth disease virus-infected but not vaccinated cattle develop antibodies against recombinant 3AB1 nonstructural protein, Arch. Virol. 142 (1997) 795-805 [CrossRef] [PubMed].
  224. Snowdon W.A., The susceptibility of some australian fauna to infection with foot-and-mouth disease virus, Aust. J. Exp. Biol. Med. Sci. 46 (1968) 667-687 [PubMed].
  225. Sobrino F., Dávila M., Ortín J., Domingo E., Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture, Virology 128 (1983) 310-318 [CrossRef] [PubMed].
  226. Sobrino F., Palma E.L., Beck E., Dávila M., de la Torre J.C., Negro P., Villanueva N., Ortín J., Domingo E., Fixation of mutations in the viral genome during an outbreak of foot-and-mouth disease: heterogeneity and rate variations, Gene 50 (1986) 149-159 [CrossRef] [PubMed].
  227. Sobrino F., Blanco E., García-Briones M., Ley V., Synthetic peptide vaccines: foot-and-mouth disease virus as a model, Dev. Biol. Stand. 101 (1999) 39-43 [PubMed].
  228. Strebel K., Beck E., A second protease of foot-and-mouth disease virus, J. Virol. 58 (1986) 893-899 [PubMed].
  229. Strohmaier K., Franze R., Adam K.H., Location and characterization of the antigenic portion of the FMDV immunizing protein, J. Gen. Virol. 59 (1982) 295-306 [PubMed].
  230. Sutmoller P., Vesicular diseases, Foreign Animal Diseases. Committee on Foreign Animal Diseases of the United States Animal Health Association, Richmond, Virginia, 1992, pp. 368-382.
  231. Sutmoller P., Gaggero A., Foot-and-mouth disease carriers, Vet. Rec. 77 (1965) 968-969.
  232. Taboga O., Tami C., Carrillo E., Núñez J.I., Rodríguez A., Sáiz J.C., Blanco E., Valero M.L., Roig X., Camarero J.A., Andreu D., Mateu M.G., Giralt E., Domingo E., Sobrino F., Palma E.L., A large scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of scape mutants, J. Virol. 71 (1997) 2606-2614 [PubMed].
  233. Thomas A.A.M., Woortmeijer R.J., Puijk W., Barteling S.J., Antigenic sites on foot-and-mouth disease virus type A10, J. Virol. 62 (1988) 2782-2789 [PubMed].
  234. Usherwood E.J., Nash A.A., Lymphocyte recognition of picornaviruses, J. Gen. Virol. 76 (1995) 499-508 [PubMed].
  235. Vakharia V.N., Devaney J., Wimmer E., Studier F.W., Dunn J.J., Proteolytic processing of foot-and-mouth disease virus polyproteins expressed in a cell free system from cloned-derived transcripts, J. Virol. 61 (1987) 3199-3207 [PubMed].
  236. van Bekkum J.G., Correlation between serum antibody level and protection against challenge with FMD. Session of Research Group of the standing Technical Committee of the European Commission for the Control of Foot and Mouth Disease, Brescia, Italy, FAO, 1969.
  237. van Bekkum J.G., Frenkel H.S., Frederiks H.H.J., Frenkel S., Observations on the carrier state of cattle exposed to foot-and-mouth disease virus, Tijdschr. Diergeneeskd. 84 (1959) 1159-1164.
  238. van Lierop M.-J.C., van Noort J.M., Wagenaar J.P.A., Rutten V.P.M.G., Langeveld J., Meloen R.H., Hensen E.J., T cell-stimulatory fragments of foot-and-mouth disease virus released by mild treatment with cathepsin D, J. Gen. Virol. 75 (1994) 2937-2946 [PubMed].
  239. van Lierop M.-J.C., Nilsson P.R., Wagenaar J.P.A., van Noort J.M., Campbell J.D.M., Glass E.J., Joosten I., Hensen E.J., The influence of MHC polymorphism on the selection of T cell determinants of foot-and-mouth disease virus in cattle, Immunology 84 (1995) 79-85 [PubMed].
  240. van Lierop M.-J.C., Wagenaar J.P.A., van Noort J.M., Hensen E.J., Sequences derived from the highly antigenic VP1 region 140-160 of foot-and-mouth disease virus do not prime for a bovine T cell response against intact virus, J. Virol. 69 (1995) 4511-4514 [PubMed].
  241. van Regenmortel M.H.V., Guichard G., Benkirane N., Briand J.-P., Muller S., Brown F., The potential of retro-inverso peptides as synthetic vaccines, in: Brown F., Haaheim L.R. (Eds). Modulation of the immune response to vaccine antigens, Karger, Basel, 1998, Vol. 92, pp. 139-143.
  242. Vangrysperre W., De Clercq K., Rapid and sensitive polymerase chain reaction based detection and typing of foot-and-mouth disease virus in clinical samples and cell culture isolates, combined with a simultaneous differentiation with other genomically and/or symptomatically related viruses, J. Virol. Methods 141 (1996) 331-344.
  243. Verdaguer N., Mateu M.G., Andreu D., Giralt E., Domingo E., Fita I., Structure of the major antigenic loop of foot-and-mouth disease virus complexed with a neutralizing antibody: direct involvement of the Arg- Gly-Asp motif in the interaction, EMBO J. 14 (1995) 1690-1696 [PubMed].
  244. Verdaguer N., Sevilla N., Valero M.L., Stuart D., Brocchi E., Andreu D., Giralt E., Domingo E., Mateu M.G., Fita I., A similar pattern of interaction for different antibodies with a major antigenic site of foot-and-mouth disease virus: implications for intratypic antigenic variation, J. Virol. 72 (1998) 739-748 [PubMed].
  245. Villinger F., Mueller H.K., Bruckner L., Ackermann M., Kihm U., Antibodies to foot-and-mouth disease virus infection associated (VIA) antigen: use of a bioengineered VIA protein as antigen in an ELISA, Vet. Microbiol. 20 (1989) 235-246 [CrossRef] [PubMed].
  246. Vosloo W., Knowles N.J., Thomson G.R., Genetic relationships between southern african SAT-2 isolates of foot-and-mouth disease virus, Epidemiol. Infect. 109 (1992) 547-558 [PubMed].
  247. Ward G., Rieder E., Mason P.W., Plasmid DNA encoding replicating foot-and-mouth disease virus genomes induces antiviral immune response in swine, J. Virol. 71 (1997) 7442-7447 [PubMed].
  248. Webster R.G., Bean W.J., Gorman O.T., Chambers T.M., Kawaoka Y., Evolution and ecology of influenza A viruses, Microbiol. Rev. 56 (1995) 152-179.
  249. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., Felgner P.L., Direct gene transfer into mouse muscle in vivo, Science 247 (1990) 1465-1468 [CrossRef].
  250. Xiang W., Andino A.V., Wimmer E., RNA signals in entero-and rhinovirus genome replication, Semin. Virol. 8 (1997) 256-273 [CrossRef].
  251. Yilma T., Morphogenesis of vesiculation in foot-and-mouth disease, Am. J. Vet. Res. 41 (1980) 1537-1542 [PubMed].
  252. Zamorano P., Wigdorovitz A., Pérez-Filguera C., Frenández F.M., Carrillo C., Marcovecchio F.E., Sadir A.M., Borca M.V., Recognition of B and T cell epitopes by cattle immunized with a synthetic peptide containing the major immunogenic site of VP1 FMDV O1 Campos, Virology 201 (1994) 383-387 [CrossRef] [PubMed].
  253. Zibert A., Maas G., Strebel K., Falk M.M., Beck E., Infectious foot-and-mouth disease virus derived from a cloned full-length cDNA, J. Virol. 64 (1990) 2467-2473 [PubMed].